SCAN-MP (Screening for Cardiac Amyloidosis with Nuclear Imaging in Minority Populations)
05/01/2019 - 02/29/2024 (Subcontract PI)Boston Medical Center Corporation NIH NHLBI5R01HL139671-02
ALA Study - Janssen Pharmaceuticals
06/09/2020 - 06/09/2023 (PI)Janssen Research & Development, LLC
Renal Immunoglobulin Light Chain Amyloidosis: Translational studies probing disease mechanism as a platform for drug development.
09/01/2018 - 08/31/2022 (PI)Florida Wildflower Foundation
Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain Amyloidosis
07/01/2020 - 06/30/2021 (Subcontract PI)The Scripps Research Institute NIH NIDDK2R01DK107604-05A1
Molecular Mechanism of Senile Cardiac Amyloidosis
09/15/2017 - 08/31/2019 (PI)NIH/National Institute on Aging2R56AG031804-06A1
Validation of blood biomarkers for recognition and monitoring of age-related, wild-type Transthyretin Amyloidosis (ATTRwt)
01/01/2018 - 12/31/2018 (PI)E. Rhodes & Leona B. Carpenter Foundation
Contribution of Immunoglobulin Constant Domain to Amyloid Formation, Part 4
01/01/2011 - 12/31/2018 (PI)Florida Wildflower Foundation
Immunohistochemical analyses of Proclara Fusion Protein, NPT189, in Amyloid-infiltrated human heart tissues
01/02/2018 - 06/30/2018 (PI)Proclara Biosciences
Congo Red Histologic Analysis for Mouse Tissue - DICERNA Pharmaceuticals, Inc.
02/22/2017 - 03/31/2017 (PI)Dicerna Pharmaceuticals, Inc.
Serum biomarker identification of cardiac amyloidosis in elderly African Americans
04/01/2016 - 03/31/2017 (Subcontract PI)Boston Medical Center Corporation NIH NIA5R21AG050206-02
Showing 10 of 19 results.
Show All Results